1-((2R,3R,4R,5R)-3,4-Dihydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidin-2(1H)-one

Catalog No.: 
ACIIPC852
CAS No.: 
1106032-88-5
Molecular Formula: 
C10H14N2O5
Molecular Weight: 
242.23
1-((2R,3R,4R,5R)-3,4-Dihydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidin-2(1H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$870.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-((2R,3R,4R,5R)-3,4-Dihydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidin-2(1H)-one
IUPAC Name1-((2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidin-2(1H)-one
Molecular FormulaC10H14N2O5
Molecular Weight242.23
SMILESO=C1N=CC=CN1[C@@H]2O[C@H](CO)[C@@H](O)[C@]2(O)C
InChI KeySMFRONCOXPTDQN-FDDDBJFASA-N
Synonym2'-C--Methyl-4-deoyuridine;2'-C--Methyl-4-deoxyuridine;2'-C-beta-Methyl-4-deoxyuridine;2’-C-beta-Methyl-4-deoxyuridine, 1-(2-beta-C-methyl-beat-D-ribofuranosyl)-2-(1H)-pyrimidinone;2’-β-C-Methyl-4-deoxyuridine;2'-C-b-Methyl-4-deoxyuridine;2(1H)-Pyrimidinone, 1-(2-C-methyl-β-D-ribofuranosyl)-;2’-C-b-Methyl-4-deoyuridine
CAS No.1106032-88-5

Synthetic Route by SureRoute

1. ACIIPC852 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIIPC852 route product structure diagram
    ACIIPC8521106032-88-5
Inquiry

2. ACIIPC852 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIIPC852 route product structure diagram
    ACIIPC8521106032-88-5
Inquiry

3. ACIIPC852 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIIPC852 route product structure diagram
    ACIIPC8521106032-88-5
Inquiry

Comments (0)